In yesterday’s Wall Street session, DURECT Corporation (NASDAQ:DRRX) shares traded at $3.29, down -33.13% from the previous session.
4 analysts cover DURECT Corporation (NASDAQ:DRRX), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $44.00 and a low of $32.00, we find $34.50. Given the previous closing price of $4.92, this indicates a potential upside of 601.22 percent. DRRX stock price is now -38.96% away from the 50-day moving average and -35.22% away from the 200-day moving average. The market capitalization of the company currently stands at $81.23M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
The stock has received a hold rating from 0 analysts and a buy rating from 4. Brokers who have rated the stock have averaged $36.25 as their price target over the next twelve months.
With the price target of $7, Chardan Capital Markets recently initiated with Buy rating for DURECT Corporation (NASDAQ: DRRX).
In other news, Robertson Judith J., Director bought 9,412 shares of the company’s stock on Aug 19. The stock was bought for $8,000 at an average price of $0.85. Upon completion of the transaction, the Director now directly owns 356,132 shares in the company, valued at $1.17 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 18, Director Robertson Judith J. bought 71,531 shares of the business’s stock. A total of $60,794 was incurred on buying the stock at an average price of $0.85. This leaves the insider owning 346,720 shares of the company worth $1.14 million. Insiders disposed of 3,498 shares of company stock worth roughly $11508.42 over the past 1 year. A total of 0.20% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in DRRX stock. A new stake in DURECT Corporation shares was purchased by ARMISTICE CAPITAL, LLC during the first quarter worth $2,007,000. CAPTION MANAGEMENT, LLC invested $543,000 in shares of DRRX during the first quarter. In the first quarter, SIMPLEX TRADING, LLC acquired a new stake in DURECT Corporation valued at approximately $357,000. PRELUDE CAPITAL MANAGEMENT, LLC acquired a new stake in DRRX for approximately $41,000. MARSHALL WACE, LLP purchased a new stake in DRRX valued at around $36,000 in the second quarter. In total, there are 69 active investors with 43.40% ownership of the company’s stock.
During the past 12 months, DURECT Corporation has had a low of $3.16 and a high of $9.70. As of last week, the company has a debt-to-equity ratio of 1.39, a current ratio of 1.20, and a quick ratio of 1.10. The fifty day moving average price for DRRX is $5.3598 and a two-hundred day moving average price translates $5.0679 for the stock.
The latest earnings results from DURECT Corporation (NASDAQ: DRRX) was released for Mar, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.47, beating analysts’ expectations of -$0.53 by 0.06. This compares to -$0.48 EPS in the same period last year. The company reported revenue of $2.05 million for the quarter, compared to $1.92 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.26 percent. For the current quarter, analysts expect DRRX to generate $2.94M in revenue.
